These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 18287600)

  • 1. Aprotinin during coronary-artery bypass grafting and risk of death.
    Schneeweiss S; Seeger JD; Landon J; Walker AM
    N Engl J Med; 2008 Feb; 358(8):771-83. PubMed ID: 18287600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of aprotinin on outcome after coronary-artery bypass grafting.
    Shaw AD; Stafford-Smith M; White WD; Phillips-Bute B; Swaminathan M; Milano C; Welsby IJ; Aronson S; Mathew JP; Peterson ED; Newman MF
    N Engl J Med; 2008 Feb; 358(8):784-93. PubMed ID: 18287601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of aprotinin on short-term and long-term outcomes after coronary artery bypass grafting surgery.
    Wang X; Zheng Z; Ao H; Zhang S; Wang Y; Zhang H; Hu S
    Ann Thorac Surg; 2010 May; 89(5):1489-95. PubMed ID: 20417766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aprotinin in cardiac surgery patients: is the risk worth the benefit?
    Stamou SC; Reames MK; Skipper E; Stiegel RM; Nussbaum M; Geller R; Robicsek F; Lobdell KW
    Eur J Cardiothorac Surg; 2009 Nov; 36(5):869-75. PubMed ID: 19782574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk associated with aprotinin in cardiac surgery.
    Mangano DT; Tudor IC; Dietzel C; ;
    N Engl J Med; 2006 Jan; 354(4):353-65. PubMed ID: 16436767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery.
    Karkouti K; Wijeysundera DN; Yau TM; McCluskey SA; Tait G; Beattie WS
    Anesth Analg; 2010 Jan; 110(1):21-9. PubMed ID: 19910626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
    Fergusson DA; Hébert PC; Mazer CD; Fremes S; MacAdams C; Murkin JM; Teoh K; Duke PC; Arellano R; Blajchman MA; Bussières JS; Côté D; Karski J; Martineau R; Robblee JA; Rodger M; Wells G; Clinch J; Pretorius R;
    N Engl J Med; 2008 May; 358(22):2319-31. PubMed ID: 18480196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
    Maslow AD; Chaudrey A; Bert A; Schwartz C; Singh A
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):6-15. PubMed ID: 18249324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary artery bypass grafting after aprotinin: are we doing better?
    Beckerman Z; Shopen Y; Alon H; Cohen O; Nir RR; Adler Z; Bolotin G
    J Thorac Cardiovasc Surg; 2013 Jan; 145(1):243-8. PubMed ID: 23072702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of aprotinin on adverse clinical outcomes and mortality up to 12 years in a registry of 3,337 patients.
    Olenchock SA; Lee PH; Yehoshua T; Murphy SA; Symes J; Tolis G
    Ann Thorac Surg; 2008 Aug; 86(2):560-6; discussion 566-7. PubMed ID: 18640334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of multiple previous percutaneous coronary interventions in patients undergoing elective coronary artery bypass surgery.
    Thielmann M; Leyh R; Massoudy P; Neuhäuser M; Aleksic I; Kamler M; Herold U; Piotrowski J; Jakob H
    Circulation; 2006 Jul; 114(1 Suppl):I441-7. PubMed ID: 16820616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal timing of coronary artery bypass after acute myocardial infarction: a review of California discharge data.
    Weiss ES; Chang DD; Joyce DL; Nwakanma LU; Yuh DD
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):503-11, 511.e1-3. PubMed ID: 18329460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aprotinin reduces bleeding and blood product use in patients treated with clopidogrel before coronary artery bypass grafting.
    Lindvall G; Sartipy U; van der Linden J
    Ann Thorac Surg; 2005 Sep; 80(3):922-7. PubMed ID: 16122456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease.
    Hannan EL; Wu C; Walford G; Culliford AT; Gold JP; Smith CR; Higgins RS; Carlson RE; Jones RH
    N Engl J Med; 2008 Jan; 358(4):331-41. PubMed ID: 18216353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aprotinin use in cardiac surgery patients at low risk for requiring blood transfusion.
    Kristeller JL; Stahl RF; Roslund BP; Roke-Thomas M
    Pharmacotherapy; 2007 Jul; 27(7):988-94. PubMed ID: 17594204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery.
    Mangano DT; Miao Y; Vuylsteke A; Tudor IC; Juneja R; Filipescu D; Hoeft A; Fontes ML; Hillel Z; Ott E; Titov T; Dietzel C; Levin J; ;
    JAMA; 2007 Feb; 297(5):471-9. PubMed ID: 17284697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aprotinin in primary cardiac surgery: operative outcome of propensity score-matched study.
    Ngaage DL; Cale AR; Cowen ME; Griffin S; Guvendik L
    Ann Thorac Surg; 2008 Oct; 86(4):1195-202. PubMed ID: 18805159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery.
    Collard CD; Body SC; Shernan SK; Wang S; Mangano DT; ;
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):392-400. PubMed ID: 16872968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of prior percutaneous coronary intervention on the outcome of coronary artery bypass surgery: a multicenter analysis.
    Massoudy P; Thielmann M; Lehmann N; Marr A; Kleikamp G; Maleszka A; Zittermann A; Körfer R; Radu M; Krian A; Litmathe J; Gams E; Sezer O; Scheld H; Schiller W; Welz A; Dohmen G; Autschbach R; Slottosch I; Wahlers T; Neuhäuser M; Jöckel KH; Jakob H
    J Thorac Cardiovasc Surg; 2009 Apr; 137(4):840-5. PubMed ID: 19327506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.